DEMURIS LIMITED
Get an alert when DEMURIS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-30
Confirmation statement due
2026-06-05 (in 1mo)
Last made up 2025-05-22
Watchouts
None on the register
Cash
£69K
Latest balance sheet
Net assets
£14K
Equity attributable
Employees
0
Average over period
Profit before tax
£3K
Period ending 2024-12-30
Net assets
10-year trend · vs Health Care median
Accounts
10-year trend · latest reflected 2024-12-30
| Metric | Trend | 2020-04-01 | 2021-03-31 | 2021-04-01 | 2021-12-30 | 2021-12-31 | 2022-12-30 | 2022-12-31 | 2023-12-30 | 2023-12-31 | 2024-12-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | £12,250 | — | £279,800 | — | £1,552,614 | — | £91,617 | — | £13,047 | |
| Operating profit | — | -£179,841 | — | -£149,196 | — | £435,188 | — | -£17,176 | — | £3,192 | |
| Profit before tax | — | -£179,810 | — | -£385,196 | — | £372,409 | — | -£16,966 | — | £3,195 | |
| Net profit | — | -£120,402 | — | -£352,920 | — | £372,409 | — | -£16,966 | — | £3,194 | |
| Cash | — | £644 | — | £57,064 | — | £10,722 | — | £167,821 | — | £69,131 | |
| Total assets less current liabilities | — | -£19,088 | — | -£108,426 | — | £159,797 | — | £11,017 | — | £14,211 | |
| Net assets | — | -£19,088 | — | -£344,426 | — | £27,983 | — | £11,017 | — | £14,211 | |
| Equity | — | -£19,088 | -£19,088 | -£344,426 | -£344,426 | £27,983 | £27,983 | £11,017 | £11,017 | £14,211 | |
| Average employees | — | 7 | — | 7 | — | 12 | — | 0 | — | 0 | |
| Wages | — | — | — | — | — | — | — | — | — | — | |
| Directors' remuneration | — | — | — | — | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-30 vs 2023-12-31
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-04-01 | 2021-03-31 | 2021-04-01 | 2021-12-30 | 2021-12-31 | 2022-12-30 | 2022-12-31 | 2023-12-30 | 2023-12-31 | 2024-12-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -53.3% | — | 28.0% | — | -18.7% | — | 24.5% | |
| Net margin | — | — | — | -126.1% | — | 24.0% | — | -18.5% | — | 24.5% | |
| Return on capital employed | — | 942.2% | — | 137.6% | — | 272.3% | — | -155.9% | — | 22.5% | |
| Current ratio | — | — | — | — | — | — | — | 1.07x | — | 1.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- DEMURIS LIMITED 2008-10-10 → present
- NUGENIS LIMITED 2007-08-28 → 2008-10-10
- NORHAM HOUSE 1120 LIMITED 2007-05-22 → 2007-08-28
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Auditor
- CFW Accountants LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a Going Concern basis. The appropriateness of the going concern basis is dependent upon continued support from the parent company which has confirmed it will maintain financial support for a period of at least 12 months from the date of these financial statements. The directors have made their own enquiries of the going concern status of the parent company and are satisfied that it is able to maintain financial support for the relevant period.”
Significant events
- “During the year the company redesignated 186 £0.01 Ordinary A shares to 186 £0.01 Ordinary shares and redesignated 695,762 £1 Preferred shares to 69,576,200 £0.01 Ordinary shares.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 13 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GLICK, Gary D. | Director | 2021-08-30 | Jun 1961 | American |
| GORDON, Carl Lee | Director | 2021-08-30 | Nov 1964 | American |
Show 13 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| F.E.LAUGHLIN LTD | Corporate Secretary | 2010-05-14 | 2022-08-26 |
| MUCKLE SECRETARY LIMITED | Corporate Secretary | 2007-05-22 | 2010-05-13 |
| BAUM, Charles | Director | 2021-08-30 | 2024-03-12 |
| BAXTER, Anthony David, Dr | Director | 2017-03-02 | 2019-07-22 |
| CARROLL, Jill Anne, Ms. | Director | 2021-08-30 | 2024-03-12 |
| ELSTOB, Philip Ronald, Dr | Director | 2013-11-12 | 2016-03-31 |
| ERRINGTON, Jeffery | Director | 2007-09-03 | 2021-08-30 |
| GORDON, Carl Lee | Director | 2021-08-30 | 2024-03-20 |
| LOCKWOOD, Robin Jeremy | Director | 2010-10-07 | 2012-12-31 |
| MATTHEWS, David Glyn | Director | 2019-09-01 | 2021-08-30 |
| ODEGARD, Valerie, Dr | Director | 2021-08-30 | 2024-03-12 |
| POMPLIANO, David Leo | Director | 2019-09-01 | 2021-08-30 |
| NORHAM HOUSE DIRECTOR LIMITED | Corporate Director | 2007-05-22 | 2007-08-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Odyssey Therapeutics, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, right-to-appoint-and-remove-directors-as-firm | 2021-08-30 | Active |
| Newcastle University Holdings Limited | Corporate entity | Shares 25–50% | 2016-04-06 | Ceased 2021-08-30 |
| Mr Jeffery Errington | Individual | Shares 25–50% | 2016-04-06 | Ceased 2021-08-30 |
Filing timeline
Last 20 of 105 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-03-26 RESOLUTIONS Resolution
- 2024-03-26 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-25 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-29 | AA | accounts | Accounts with accounts type full | |
| 2025-05-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-06-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-04-26 | SH08 | capital | Capital name of class of shares | |
| 2024-04-26 | SH10 | capital | Capital variation of rights attached to shares | |
| 2024-03-26 | RESOLUTIONS | resolution | Resolution | |
| 2024-03-26 | MA | incorporation | Memorandum articles | |
| 2024-03-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-20 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-08 | AA | accounts | Accounts with accounts type full | |
| 2023-05-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-16 | AA | accounts | Accounts with accounts type full | |
| 2022-09-23 | AA01 | accounts | Change account reference date company previous shortened | |
| 2022-09-20 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-05-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-02-08 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.